WUN News - Wake Up Narcolepsy

Jun 17 2025

SLEEP Meeting 2025 Recap

Wake Up Narcolepsy (WUN) representatives are always excited to attend the annual SLEEP Meeting hosted...

10:38 / News

Jun 11 2025

Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Jun. 11, 2025-- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the presentation of...

11:44 / News

Jun 11 2025

Showcasing Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025

DUBLIN, June 9, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced late-breaking Phase 4 data evaluating treatment benefits of Xywav® (calcium, magnesium,...

09:37 / News

Jun 05 2025

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines...

10:39 / News

Jun 02 2025

Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025

DUBLIN, May 29, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to...

13:24 / News

May 30 2025

Jazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) in Sleep Conditions and Associated Comorbidities at SLEEP 2025

DUBLIN, May 29, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that nineteen abstracts, including eleven late-breaking abstracts will be presented at SLEEP...

08:40 / News